Human CD30/TNFRSF8 (Research Grade Brentuximab Biosimilar) Biotinylated Antibody
Human CD30/TNFRSF8 (Research Grade Brentuximab Biosimilar) Biotinylated Antibody Summary
Applications
Please Note: Optimal dilutions should be determined by each laboratory for each application. General Protocols are available in the Technical Information section on our website.
Scientific Data

Detection of CD30/TNFRSF8 in Jurkat human acute T cell leukemia cell line by Flow Cytometry. Jurkat human acute T cell leukemia cell line was stained with Human Anti-Human CD30/TNFRSF8 (Brentuximab Biosimilar) Biotinylated Monoclonal Antibody (Catalog # FAB9576B, filled histogram) or irrelevant biotinylated antibody (open histogram) followed by PE-conjugated Streptavidin (Catalog # F0040). View our protocol for Staining Membrane-associated Proteins.
Preparation and Storage
- 12 months from date of receipt, 2 to 8 °C as supplied.
Background: CD30/TNFRSF8
Brentuximab is a biosimilar directed against the extracellular domain of CD30. This biotinylated antibody can be used in flow cytometry or various assay format to measure CD30 expression and can be detected by conjugated streptavidin.
Product Datasheets
Product Specific Notices
Brentuximab is a biosimilar expressed in Hek293 cells and is intended for research use only.FAQs
No product specific FAQs exist for this product, however you may
View all Antibody FAQsReviews for Human CD30/TNFRSF8 (Research Grade Brentuximab Biosimilar) Biotinylated Antibody
There are currently no reviews for this product. Be the first to review Human CD30/TNFRSF8 (Research Grade Brentuximab Biosimilar) Biotinylated Antibody and earn rewards!
Have you used Human CD30/TNFRSF8 (Research Grade Brentuximab Biosimilar) Biotinylated Antibody?
Submit a review and receive an Amazon gift card.
$25/€18/£15/$25CAN/¥75 Yuan/¥2500 Yen for a review with an image
$10/€7/£6/$10 CAD/¥70 Yuan/¥1110 Yen for a review without an image